Showing 1 - 10 results of 10 for search 'S. Knackmuss', query time: 0.03s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies by Kristina Ellwanger, Uwe Reusch, Ivica Fucek, Stefan Knackmuss, Michael Weichel, Thorsten Gantke, Vera Molkenthin, Eugene A. Zhukovsky, Michael Tesar, Martin Treder
Published 2017-05-01
Article -
7
Co- but not Sequential Infection of DCs Boosts Their HIV-Specific CTL-Stimulatory Capacity by Manuela Schönfeld, Ulla Knackmuss, Parul Chandorkar, Paul Hörtnagl, Thomas John Hope, Arnaud Moris, Arnaud Moris, Rosa Bellmann-Weiler, Cornelia Lass-Flörl, Wilfried Posch, Doris Wilflingseder
Published 2019-05-01
Article -
8
Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity. by Kerrilyn Naidoo, Sibusiso T Malindisa, Tyrone C Otgaar, Martin Bernert, Bianca Da Costa Dias, Eloise Ferreira, Uwe Reusch, Stefan Knackmuss, Melvyn Little, Stefan F T Weiss, Boitelo T Letsolo
Published 2015-01-01
Article -
9
P482: NOVEL BISPECIFIC INNATE CELL ENGAGER AFM28 FOR THE TREATMENT OF CD123 POSITIVE ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME by J.-J. Siegler, N. Schmitt, J. Pahl, T. Haneke, I. Kozlowska, S. Sarlang, A. Beck, S. Knackmuss, P. Ravenstijn, U. Reusch, J. Medina-Echeverz, J. Endell, T. Ross, D. Nowak, C. Merz
Published 2022-06-01
Article -
10
Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors by Susanne Wingert, Uwe Reusch, Stefan Knackmuss, Michael Kluge, Michael Damrat, Jens Pahl, Ute Schniegler-Mattox, Thomas Mueller, Ivica Fucek, Kristina Ellwanger, Michael Tesar, Torsten Haneke, Joachim Koch, Martin Treder, Wolfgang Fischer, Erich Rajkovic
Published 2021-01-01
Article